“Not all high writers are high opportunity—and not all low writers are low potential.” The Truth About Life Sciences Marketing There’s a dirty little secret in life sciences

“In the battle for access, the best tool isn’t just a rebate—it’s real-time intelligence.” Access Strategy Is Evolving Fast Payer access has always been a battlefield, but the

“If the provider doesn’t know the drug is affordable, the prescription may never get written. If the patient doesn’t know, it may never get filled.” Pharma brands spend

“It’s not the prescription that changes lives—it’s the fill.” In pharma, NBRx (new-to-brand prescriptions) is the metric everyone chases. But what happens after the prescription is written often

“If your segmentation strategy still revolves around deciles, you’re playing checkers in a chess match.” Physician-level data (PLD) revolutionized the way pharma thinks about its customers.It didn’t just

“If your EHR strategy starts and ends with ‘we’re in Epic,’ then you don’t have a strategy.” For years, pharmaceutical brands have treated Epic—and EHRs in general—like a